(Q45258653)

English

Clinicopathological predictors of systemic progression and prostate cancer mortality in patients with a positive surgical margin at radical prostatectomy

scientific article published on 2 August 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Clinicopathological predictors of systemic progression and prostate cancer mortality in patients with a positive surgical margin at radical prostatectomy (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

author name string

S A Boorjian

1

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

M K Tollefson

2

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

L J Rangel

3

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

E J Bergstralh

4

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

R J Karnes

5

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

publication date

2 August 2011

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Prostate Cancer and Prostatic Diseases

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

15

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

56-62

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

https://scigraph.springernature.com/pub.10.1038/pcan.2011.36

0 references

Impact of positive surgical margins after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.36

21 January 2018

Use of Gleason score, prostate specific antigen, seminal vesicle and margin status to predict biochemical failure after radical prostatectomy.

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.36

21 January 2018

Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.36

21 January 2018

Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.36

21 January 2018

Incidence, etiology, location, prevention and treatment of positive surgical margins after radical prostatectomy for prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.36

21 January 2018

Predictive significance of surgical margin status after prostatectomy for prostate cancer during PSA era.

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.36

21 January 2018

Incidence and significance of positive margins in radical prostatectomy specimens

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.36

21 January 2018

Prognostic impact of positive surgical margins in surgically treated prostate cancer: multi-institutional assessment of 5831 patients

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.36

21 January 2018

Prognostic Significance of Location of Positive Margins in Radical Prostatectomy Specimens

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.36

21 January 2018

Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.36

21 January 2018

Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.36

21 January 2018

Long-term risk of clinical progression after biochemical recurrence following radical prostatectomy: the impact of time from surgery to recurrence.

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.36

21 January 2018

Vaporization of prostates of > or =80 mL using a potassium-titanyl-phosphate laser: midterm-results and comparison with prostates of <80 mL.

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.36

21 January 2018

Positive surgical margins at radical prostatectomy predict prostate cancer specific mortality

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.36

21 January 2018

Defining prostate specific antigen progression after radical prostatectomy: what is the most appropriate cut point?

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.36

21 January 2018

Defining Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy: A Proposal for a Standardized Definition

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.36

21 January 2018

Risk stratification for biochemical recurrence in men with positive surgical margins or extracapsular disease after radical prostatectomy: results from the SEARCH database

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.36

21 January 2018

Impact of positive surgical margins after radical prostatectomy differs by disease risk group

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.36

21 January 2018

Identification of patients with prostate cancer who benefit from immediate postoperative radiotherapy: EORTC 22911.

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.36

21 January 2018

Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.36

21 January 2018

Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.36

21 January 2018

Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95.

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.36

21 January 2018

Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.36

21 January 2018

Patterns of secondary cancer treatment for biochemical failure following radical prostatectomy: data from CaPSURE.

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.36

21 January 2018

Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911)

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.36

31 March 2020

The Actual Value of the Surgical Margin Status as a Predictor of Disease Progression in Men with Early Prostate Cancer

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.36

31 March 2020

The impact of positive surgical margins on mortality following radical prostatectomy during the prostate specific antigen era

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.36

31 March 2020

Prostate specific antigen recurrence rates are low after radical retropubic prostatectomy and positive margins

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.36

31 March 2020

Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.36

31 March 2020

The Long-Term Clinical Impact of Biochemical Recurrence of Prostate Cancer 5 or More Years After Radical Prostatectomy

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.36

31 March 2020

Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.36

31 March 2020

Staging of prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.36

31 March 2020

Defining pathological variables to predict biochemical failure in patients with positive surgical margins at radical prostatectomy: implications for adjuvant radiotherapy

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.36

31 March 2020

Biochemical recurrence after radical prostatectomy: multiplicative interaction between surgical margin status and pathological stage

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.36

31 March 2020

Location, extent and number of positive surgical margins do not improve accuracy of predicting prostate cancer recurrence after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.36

31 March 2020

Overall survival benefit from postoperative radiation therapy for organ-confined, margin-positive prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.36

31 March 2020

Radiation therapy after radical prostatectomy: impact on metastasis and survival

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.36

31 March 2020

Identifiers

10.1038/PCAN.2011.36

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45258653&oldid=2071836890"